Novo Nordisk's head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the ...
Stocktwits on MSN1d
Novo Nordisk’s Controlling Shareholder Novo Holdings Reports Record Total Income, Investment Returns In 2024: Retail Stays BullishNovo Holdings, the controlling shareholder of drug maker Novo Nordisk, said on Wednesday that its total income and investment ...
First, Novo Nordisk is expanding its program to sell Wegovy GLP-1 weight loss drugs at discounted prices. Second, Novo is ...
A 25-year insider at Novo Nordisk, Jørgensen took the helm in January this year, and brought in new cost control measures, including job losses of 1,000 employees.
Novo Nordisk to Pay $2 Billion for New Weight Loss Drug TUESDAY, March 25, 2025 (HealthDay News) -- Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion ...
This article has been corrected to reflect Novo Nordisk made its announcement Wednesday. Investopedia requires writers to use primary sources to support their work. These include white papers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback